New rapid report by IQWiG
The IQWiG not only examines the benefits and harms of medical interventions for early benefit assessments but also produces independent, evidence-based reports
Category: News and updates
Negotiated reimbursement price applicable 12 months after launch
The IQWiG methods will be updated again
The IQWiG has just published draft version 6.1 of its “General methods”. The General Methods describe the work procedures of the IQWiG,
The G-BA starts the development of a new DMP for obesity
This new DMP for obesity should consider and combine various therapeutic approaches to offer the best possible care, treat patients with obesity
Reimbursement in Germany in real practice
We do often talk about pharmaceutical companies aiming to achieve “reimbursement” for the products, but what does that actually mean in real